Ask Our Doctors and Nurses!

XOPENEX Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

XOPENEX Safety Reports

Total XOPENEX reports: 125.
XOPENEX FDA safety alerts: No.
Reported deaths: 5    Reported hospitalizations: 112.
Take XOPENEX Side Effects Survey or Share Your XOPENEX Story. Read More Here.

Showing 1-75 of 125 Next >

Consumer or non-health professional from UNITED STATES reported XOPENEX problem on Sept 11, 2006. Female patient, child 10 years of age, weighting 64.00 lb, was diagnosed with asthma and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: asthma, condition aggravated, cyanosis. XOPENEX dosage: unknown. During the same period patient was treated with ALBUTEROL, ATROVENT, ADVAIR DISKUS, PREDNISONE, DUONEB, FORADIL. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Pharmacist from UNITED STATES on Sept 13, 2006. Female patient was diagnosed with asthma, bronchitis and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: choking, foreign body aspiration, sensation of foreign body. XOPENEX dosage: unknown. During the same period patient was treated with FENTANYL, ALBUTEROL, AMBIEN, XANAX, SINGULAIR, ASPIRIN, MAXZIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Sept 12, 2006. Female patient, child 5 years of age, was diagnosed with wheezing and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: convulsion. XOPENEX dosage: 1.25 MG/3ML; 1X; INHALATION. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Sept 12, 2006. Female patient, child 5 years of age, was diagnosed with wheezing and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: convulsion. XOPENEX dosage: 1.25 MG/3ML; 1X; INHALATION. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XOPENEX problem on Sept 26, 2006. Male patient, 13 years of age, was diagnosed with asthma and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: asthma, chills, condition aggravated, feeling jittery, gastrooesophageal reflux disease, heart rate increased, muscular weakness. XOPENEX dosage: unknown. During the same period patient was treated with ADVAIR HFA, PULMICORT, EPIPEN, CROMOLYN. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 87 years of age, weighting 155.0 lb, was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, cough, dizziness, dyspnoea, feeling abnormal, lung disorder, transfusion. XOPENEX dosage: 45 MG; TID; INHALATION. During the same period patient was treated with FORMOTEROL, PROVENTIL, ASMANEX TWISTHALER, MUCINEX, AIRET, ATROVENT, MICRO, SIMVASTATIN. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Oct 03, 2006. Female patient, 54 years of age, weighting 189.6 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: bronchitis. XOPENEX dosage: 1.25 MG/3ML; PRN; INHALATION. During the same period patient was treated with TORSEMIDE, CLONIDINE, POTASSIUM ACETATE, LORAZEPAM, FLOVENT, METHADONE. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Oct 09, 2006. Male patient, 71 years of age, weighting 201.3 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, bundle branch block left, bundle branch block right, chest discomfort, chronic obstructive pulmonary disease, condition aggravated, electrocardiogram st-t change, international normalised ratio increased, prothrombin time prolonged. XOPENEX dosage: unknown. During the same period patient was treated with AMLODIPINE, DIGITEK, PREVACID, FLOVENT, PROPOXYPHENE HYDROCHLORIDE, LISINOPRIL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Oct 12, 2006. Male patient, 60 years of age, weighting 198.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: body temperature increased, chronic obstructive pulmonary disease, condition aggravated, loss of consciousness. XOPENEX dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, METOPROLOL TARTRATE, VALSARTAN, PANTOPRAZOLE, INSULIN, ASPIRIN, FLONASE. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Oct 12, 2006. Male patient, 74 years of age, weighting 149.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, pneumonia. XOPENEX dosage: 45 MG/3ML; PRN; INHALATION. During the same period patient was treated with ASPIRIN, SIMVASTATIN, TAMSULOSIN, LOTREL, FLONASE, DIFLUCAN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Oct 16, 2006. Male patient, 60 years of age, weighting 142.2 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: pneumonia. XOPENEX dosage: unknown. During the same period patient was treated with VERAPAMIL, XANAX, METHADONE, BACLOFEN, EXCEDRIN, ROLAIDS, LYRICA. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Male patient, 66 years of age, weighting 169.3 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: adrenal disorder, angina unstable, coronary artery disease, myocardial ischaemia. XOPENEX dosage: 90 MG/3ML; PRN; INHALATION. During the same period patient was treated with PRILOSEC, OXYGEN, ASMANEX TWISTHALER, ATROVENT, LACTOBACILLUS ACIDOPHILUS, VITAMINS. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Oct 27, 2006. Male patient was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: status asthmaticus. XOPENEX dosage: unknown. During the same period patient was treated with PROVENTIL, SINGULAIR, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Oct 19, 2006. Female patient, 54 years of age, weighting 189.6 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: bronchitis. XOPENEX dosage: 1.25MG/3ML;PRN;INHALATION. During the same period patient was treated with TORSEMIDE, CLONIDINE, POTASSIUM ACETATE, LORAZEPAM, FLOVENT, METHADONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XOPENEX problem on Oct 20, 2006. Female patient, 68 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, treatment noncompliance. XOPENEX dosage: unknown. During the same period patient was treated with ATROVENT, OXYGEN. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2006. Female patient, 68 years of age, weighting 122.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, upper respiratory tract infection. XOPENEX dosage: 1.25 MG/3ML; TID; INHALATION - SEE IMAGE. During the same period patient was treated with ATROVENT, OXYGEN, METOPROLOL, LISINOPRIL, LASIX, ACTONEL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Oct 25, 2006. Male patient, 74 years of age, weighting 149.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, pneumonia. XOPENEX dosage: 45 MG/3ML; PRN; INHALATION. During the same period patient was treated with ASPIRIN, SIMVASTATIN, TAMSULOSIN, LOTREL, FLONASE, DIFLUCAN. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2006. Female patient, 68 years of age, weighting 122.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, tremor, upper respiratory tract infection. XOPENEX dosage: 1.25 MG/3ML; TID; INHALATION; SEE IMAGE. During the same period patient was treated with ATROVENT, OXYGEN, METOPROLOL, LISINOPRIL, LASIX, ACTONEL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Oct 25, 2006. Male patient, 74 years of age, weighting 149.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: asthenia, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, lung infiltration, pneumonia, white blood cell count increased. XOPENEX dosage: 45 MG/3ML; PRN; INHALATION. During the same period patient was treated with ASPIRIN, SIMVASTATIN, TAMSULOSIN, LOTREL, FLONASE, DIFLUCAN. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Oct 30, 2006. Male patient, 60 years of age, weighting 198.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: body temperature increased, chronic obstructive pulmonary disease, heart rate increased, hepatic steatosis, loss of consciousness. XOPENEX dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, METOPROLOL SUCCINATE, VALSARTAN, PANTOPRAZOLE, INSULIN, ASPIRIN, FLONASE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Oct 16, 2006. Male patient, 60 years of age, weighting 142.2 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: adrenal neoplasm, aortic arteriosclerosis, atrial fibrillation, atrial tachycardia, blood glucose increased, blood sodium decreased, bullous lung disease, clavicle fracture, conduction disorder. XOPENEX dosage: unknown. During the same period patient was treated with VERAPAMIL, XANAX, METHADONE, BACLOFEN, EXCEDRIN, ROLAIDS, LYRICA. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Male patient, 71 years of age, weighting 119.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: breath sounds abnormal, cardiac failure congestive, cardiomegaly, chronic obstructive pulmonary disease, electrocardiogram poor r-wave progression, electrocardiogram t wave inversion, scoliosis, sinus tachycardia, weight increased. XOPENEX dosage: unknown. During the same period patient was treated with THEOPHYLLINE, ALBUTEROL, ATROVENT, PREDNISONE, PULMICORT, TAMSULOSIN, ALBUTEROL W, GUAIFENESIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported XOPENEX problem on Nov 10, 2006. Female patient, 78 years of age, was diagnosed with bronchitis, nasopharyngitis and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, stridor. XOPENEX dosage: 1.25 MG/3ML; 1X; INHALATION. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ALTACE, PLAVIX, PANTOPRAZOLE, VITAMIN B, LEVOTHYROXINE, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Nov 09, 2006. Male patient, 71 years of age, weighting 119.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, brain natriuretic peptide increased, cardiac failure congestive, cardiomegaly, chronic obstructive pulmonary disease, condition aggravated, electrocardiogram poor r-wave progression, electrocardiogram t wave inversion, scoliosis. XOPENEX dosage: unknown. During the same period patient was treated with THEOPHYLLINE, ALBUTEROL, ATROVENT, PREDNISONE, PULMICORT, TAMSULOSIN, ALBUTEROL W, GUAIFENESIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported XOPENEX problem on Nov 16, 2006. Male patient, 53 years of age, was diagnosed with respiratory distress and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: bronchospasm, stridor, vocal cord disorder. XOPENEX dosage: 1.25 MG/3ML;1X; INHALATION; SEE IMAGE. During the same period patient was treated with PROPOFOL, SYNTHROID, FLUCONAZOLE, VITAMIN CAP, FOLIC ACID, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Nov 17, 2006. Male patient, 60 years of age, weighting 198.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood ph increased, chronic obstructive pulmonary disease, condition aggravated, cough, dyspnoea, heart rate increased, hepatic steatosis. XOPENEX dosage: unknown. During the same period patient was treated with ATORVASTATIN, METOPROLOL SUCCINATE, VALSARTAN, PANTOPRAZOLE, INSULIN, ASPIRIN, FLONASE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Nov 28, 2006. Male patient, 71 years of age, weighting 119.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chronic obstructive pulmonary disease, electrocardiogram poor r-wave progression, electrocardiogram t wave inversion, sinus tachycardia, troponin increased. XOPENEX dosage: unknown. During the same period patient was treated with THEOPHYLLINE, ALBUTEROL, ATROVENT, PREDNISONE, PULMICORT, TAMSULOSIN, ALBUTEROL W, GUAIFENESIN. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 30, 2006. Female patient was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hyperventilation, musculoskeletal stiffness. XOPENEX dosage: unknown. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on Dec 06, 2006. Female patient, 69 years of age, weighting 233.5 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease. XOPENEX dosage: unknown. During the same period patient was treated with FLUOXETINE, PIROXICAM, CALCIUM, VITAMIN CAP, ASPIRIN, OXYGEN. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on June 28, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, heart rate irregular. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, REQUIP, DOXAZOSIN MESYLATE, ATROVENT. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on June 28, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, heart rate irregular. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, REQUIP, DOXAZOSIN MESYLATE, ATROVENT. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lung neoplasm, lymphadenopathy mediastinal, lymphocyte percentage decreased. XOPENEX dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on June 25, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, computerised tomogram abnormal, condition aggravated, eosinophil count increased, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lymphadenopathy mediastinal. XOPENEX dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on July 02, 2007. Female patient, 77 years of age, weighting 192.5 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose increased, blood pressure systolic increased, chest pain, hyperhidrosis, nausea, protein urine present, rhonchi, sleep apnoea syndrome. XOPENEX dosage: unknown. During the same period patient was treated with LISINOPRIL, LUNESTA, ASPIRIN, IBUPROFEN, ATROVENT, DOLOMITE, VITAMIN B CAP, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported XOPENEX problem on July 24, 2007. Female patient, weighting 162.0 lb, was diagnosed with asthma and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, confusional state, dizziness, headache, hyperhidrosis, muscle spasms, nausea, pollakiuria. XOPENEX dosage: unknown. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. XOPENEX dosage: 1.25 MG/3ML; PRN; INHALATION. During the same period patient was treated with OXYGEN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XOPENEX problem on July 20, 2007. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. XOPENEX dosage: 1.25 MG/3 ML; PRN; INHALATION. During the same period patient was treated with OXYGEN. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2007. Male patient, 66 years of age, was diagnosed with bronchitis, chronic obstructive pulmonary disease, emphysema and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: breath odour, dysgeusia, heart rate increased, viral infection. XOPENEX dosage: 1.25 MG3ML;TID;INHALATION. During the same period patient was treated with XOPENEX HFA, XOPENEX HFA, XOPENEX HFA, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on July 25, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, coronary artery disease, coronary artery occlusion, electrocardiogram st-t change, oxygen saturation decreased, troponin increased. XOPENEX dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, REQUIP, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Female patient, 86 years of age, weighting 105.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, ill-defined disorder, rash, unevaluable event. XOPENEX dosage: 1.25 MG; INHALATION. During the same period patient was treated with TIOTROPIUM, PULMICORT, OXYGEN, LISINOPRIL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on July 26, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: arrhythmia, atrial tachycardia, blood pressure increased, cardiac disorder, chest discomfort, chronic obstructive pulmonary disease, coronary artery disease, heart rate increased, respiratory rate increased. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, REQUIP, DOXAZOSIN MESYLATE, ATROVENT. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on July 25, 2007. Male patient, 76 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: foreign body trauma, haematocrit decreased, haemoglobin decreased, oesophageal discomfort, oesophageal food impaction, spinal osteoarthritis. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, LORCET, GEMFIBROZIL, TAMSULOSIN, PRINZIDE, CYANOCOBALAMIN, TYLENOL, PAROXETINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XOPENEX problem on July 25, 2007. Male patient, 76 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: calcinosis, dysphagia, foreign body trauma, haematocrit decreased, haemoglobin decreased, oesophageal discomfort, oesophageal food impaction, renal failure, spinal osteoarthritis. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, LORCET, GEMFIBROZIL, TAMSULOSIN, PRINZIDE, CYANOCOBALAMIN, TYLENOL, PAROXETINE. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, 84 years of age, weighting 140.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: emphysema, panic disorder, respiratory tract infection. XOPENEX dosage: 1.25 MG/3ML; 1X; INHALATION. During the same period patient was treated with ALBUTEROL, FOLIC ACID, HYZAAR, VITAMIN CAP, TIOTROPIUM BROMIDE, OXYGEN. Patient died on 07/09/2007.

Physician from UNITED STATES reported XOPENEX problem on Aug 16, 2007. Male patient, 57 years of age, weighting 309.7 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, leukocytosis. XOPENEX dosage: unknown. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Male patient, 65 years of age, was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: bronchiectasis, cardiac arrest, chronic obstructive pulmonary disease, clostridium difficile colitis, fungal infection, hyperkalaemia, lung infection, lung infiltration, pneumonia. XOPENEX dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PREDNISONE, BROVANA. Patient was hospitalized. Patient died on 08/21/2007.

Physician from UNITED STATES reported XOPENEX problem on Aug 20, 2007. Male patient, 68 years of age, weighting 254.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: bronchitis, condition aggravated. XOPENEX dosage: unknown. During the same period patient was treated with LASIX, AVAPRO, VITAMIN B CAP, NEXIUM, ATROVENT, LEVITRA. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Physician from UNITED STATES on Aug 28, 2007. Male patient, 50 years of age, weighting 161.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, acute myocardial infarction, blood albumin decreased, blood cholesterol increased, blood potassium decreased, blood urea increased, cardiac failure congestive, cardiac ventricular disorder, coronary artery occlusion. XOPENEX dosage: unknown. During the same period patient was treated with ALBUTEROL, PEPTO, IBUPROFEN, ATROVENT. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported XOPENEX problem on Sept 10, 2007. Male patient, 72 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, dyspnoea, oxygen saturation decreased, rales, respiratory disorder, respiratory fume inhalation disorder, wheezing, white blood cell count increased. XOPENEX dosage: 1.25 MG/3ML; INHALATION; 1.25 PRN; INHALATION; 0.63 QID, INHALATION. During the same period patient was treated with PREDNISONE, TAMSULOSIN, HYDROCHLORIDE, ALPRAZOLAM, FORMOTEROL FUMARATE, BROVANA, ALBUTEROL W. Patient was hospitalized. Patient recovered.

XOPENEX problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Male patient, 72 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, respiratory fume inhalation disorder, white blood cell count increased. XOPENEX dosage: 1.25 MG/3ML; ; INHALATION, 1.25; PRN; INHALATION, 0.63; QID; INHALATION. During the same period patient was treated with PREDNISONE, TAMSULOSIN HYDROCHLORIDE, ALPRAZOLAM, FORMOTEROL FUMARATE, BROVANA, ALBUTEROL W, DILTIAZEM. Patient was hospitalized. Patient recovered.

Showing 1-75 of 125 Next >